Chronic Lymphocytic Leukemia Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Ask the CLL doctor video series with Dr Claire Dearden (Part 2)
Dr Claire Dearden, Consultant Haematologist and Head of the Chronic Lymphocytic Leukaemia (CLL) Unit at The Royal Marsden and The Institute of Cancer Research, answers questions about: • Infection ... Author: PatientPowerEU Added: 03/29/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 29, 2015 Category: Cancer & Oncology Source Type: podcasts

Ask the CLL doctor video series with Dr Claire Dearden (Part 1)
Dr Claire Dearden, Consultant Haematologist and Head of the Chronic Lymphocytic Leukaemia (CLL) Unit at The Royal Marsden and The Institute of Cancer Research, answers questions about: • Cost of th... Author: PatientPowerEU Added: 03/29/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 29, 2015 Category: Cancer & Oncology Source Type: podcasts

RESONAT-2 Trial Predictions for Patients With CLL
Upcoming RESONAT-2 trial results for patients with chronic lymphocytic leukemia (CLL). William G. Weirda, MD, PhD, medical director of the Leukemia Center at The University of Texas MD Anderson Cance... Author: onclivetv Added: 03/23/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 23, 2015 Category: Cancer & Oncology Source Type: podcasts

Ibrutinib and Idelalisib For CLL
The mechanisms of ibrutinib and idelalisib for the treatment of chronic lymphocytic leukemia (CLL). Thomas Kipps, MD, PhD, Division of Hematology-Oncology Deputy Director for Research at the UC San D... Author: onclivetv Added: 03/06/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 6, 2015 Category: Cancer & Oncology Source Type: podcasts

Julia's story: From CLL diagnosis to a doctorate study of how CLL people use the internet
Julia shares with us: her experience of diagnosis with chronic lymphocytic leukaemia (CLL); her first questions and the general doctor's knowledge; how being selective when sourcing information is imp... Author: PatientPowerEU Added: 02/18/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 18, 2015 Category: Cancer & Oncology Source Type: podcasts

Andy’s story: CLL diagnosis, challenges of understanding and watch and wait
Andy shares with us: what led to his diagnosis of chronic lymphocytic leukaemia (CLL); how he received the news, the conflicting message and how this impacted him; his challenges living with symptoms ... Author: PatientPowerEU Added: 02/17/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 17, 2015 Category: Cancer & Oncology Source Type: podcasts

Jan's Story: CLL diagnosis, treatment and family, gaining information and meeting others with CLL
Jan shares with us: how her diagnosis of chronic lymphocytic leukaemia (CLL) altered her life; how the support of her family helped her through treatment; how joining the CLL Support Association (CLLS... Author: PatientPowerEU Added: 02/17/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 17, 2015 Category: Cancer & Oncology Source Type: podcasts

Kirk's story: CLL diagnosis, adjusting with time, information and connecting with others with CLL
Kirk shares with us: his chronic lymphocytic leukaemia (CLL) diagnosis; how little information accompanied it; how he gained information from groups, such as the CLL Support Association (CLLSA) and th... Author: PatientPowerEU Added: 02/17/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 17, 2015 Category: Cancer & Oncology Source Type: podcasts

Arthur outlines the CLLSA and the importance of extending resources to support CLL patients
Arthur, a chronic lymphocytic leukaemia (CLL) patient and Chair of the Chronic Lymphocytic Leukaemia Support Association (CLLSA), shares with us how the CLLSA supports people affected by CLL, includin... Author: PatientPowerEU Added: 02/17/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 17, 2015 Category: Cancer & Oncology Source Type: podcasts

Prof John Gribben and Prof Peter Hillmen at ASH 2014: Early treatment versus ‘watch and wait’ for CLL
Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Peter Hillmen (Leeds General Infirmary, UK) about recent advances in the research of chronic lymphocytic leukaemia (CLL) that wer... Author: PatientPowerEU Added: 02/02/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 2, 2015 Category: Cancer & Oncology Source Type: podcasts

Dr Barbara Eichhorst at ASH 2014: New therapies for CLL, including ABT-199, ibrutinib and idelalisib
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Barbara Eichhorst (University Hospital, Cologne, Germany) discusses research in new agents for chronic lymphocytic leukaemia (CLL) p... Author: PatientPowerEU Added: 01/29/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2015 Category: Cancer & Oncology Source Type: podcasts

Prof John Gribben and Prof Peter Hillmen at ASH 2014: New combination therapies provide great opportunities for CLL
Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Peter Hillmen (Leeds General Infirmary, UK) about recent advances in the research of chronic lymphocytic leukaemia (CLL) that wer... Author: PatientPowerEU Added: 01/29/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2015 Category: Cancer & Oncology Source Type: podcasts

New drugs showing promise for CLL patients at ASH 2014: A discussion between Prof John Gribben and Prof Peter Hillmen
Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Peter Hillmen (Leeds General Infirmary, UK) about recent advances in the research of chronic lymphocytic leukaemia (CLL) that wer... Author: PatientPowerEU Added: 01/27/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 27, 2015 Category: Cancer & Oncology Source Type: podcasts

Dr George Follows at ASH 2014: Management of CLL
Dr George Follows provides an overview of results of clinical trials in chronic lymphocytic leukaemia (CLL) presented at the 2014 American Society of Hematology (ASH) Annual Meeting. He considers the ... Author: EMJ Added: 01/27/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 27, 2015 Category: Cancer & Oncology Source Type: podcasts

Progress in Understanding CLL Genetics
Dr. Jennifer Brown, director of the Chronic Lymphocytic Leukemia Center at Dana-Farber Cancer Institute, joined Patient Power at the 2014 American Society of Hematology (ASH) meeting to provide an upd... Author: patientpower Added: 01/21/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 22, 2015 Category: Cancer & Oncology Source Type: podcasts